Centrosome defects and genetic instability in malignant tumors.

Genetic instability is a common feature of many human cancers. This condition is frequently characterized by an abnormal number of chromosomes, although little is known about the mechanism that generates this altered genetic state. One possibility is that chromosomes are missegregated during mitosis due to the assembly of dysfunctional mitotic spindles. Because centrosomes are involved in spindle assembly, they could contribute to chromosome missegregation through the organization of aberrant spindles. As an initial test of this idea, we examined malignant tumors for centrosome abnormalities using antibodies to the centrosome protein pericentrin. We found that centrosomes in nearly all tumors and tumor-derived cell lines were atypical in shape, size, and composition and were often present in multiple copies. In addition, virtually all pericentrin-staining structures in tumor cells nucleated microtubules, and they participated in formation of disorganized mitotic spindles, upon which chromosomes were missegregated. All tumor cell lines had both centrosome defects and abnormal chromosome numbers, whereas neither was observed in nontumor cells. These results indicate that centrosome defects are a common feature of malignant tumors and suggest that they may contribute to genetic instability in cancer.

[1]  J. McIntosh,et al.  Mitosis , 1951, Methods in Molecular Biology.

[2]  A. Norton,et al.  Brief, high‐temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues , 1994, The Journal of pathology.

[3]  P. Calarco,et al.  Absence of centrioles in the first and second meiotic spindles of mouse oocytes. , 1972, Journal of cell science.

[4]  V. Freedman,et al.  Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. , 1974, Cell.

[5]  Nicklas Rb.  How Cells Get the Right Chromosomes , 1997, Science.

[6]  E. Stanbridge,et al.  Analysis of malignancy in human cells: malignant and transformed phenotypes are under separate genetic control. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[7]  B. Alberts,et al.  The centrosome and cellular organization. , 1994, Annual review of biochemistry.

[8]  L. Hartwell,et al.  Cell cycle control and cancer. , 1994, Science.

[9]  Amanda G Paulovich,et al.  When Checkpoints Fail , 1997, Cell.

[10]  M. Winey.  Genome stability: Keeping the centrosome cycle on track , 1996, Current Biology.

[11]  J. Dick,et al.  Normal and leukemic human stem cells assayed in SCID mice. , 1996, Seminars in immunology.

[12]  J Schumann,et al.  Cellular DNA content as a marker of neoplasia in man. , 1980, The American journal of medicine.

[13]  M. Kirschner,et al.  Pericentrin, a highly conserved centrosome protein involved in microtubule organization , 1994, Cell.

[14]  W. Wells.  The spindle-assembly checkpoint: aiming for a perfect mitosis, every time. , 1996, Trends in cell biology.

[15]  D. Lydall,et al.  Cell cycle checkpoints, genetic instability and cancer. , 1993, Seminars in cancer biology.

[16]  Marc W. Kirschner,et al.  How Proteolysis Drives the Cell Cycle , 1996, Science.

[17]  C. Vidair,et al.  Pericentrin and γ-Tubulin Form a Protein Complex and Are Organized into a Novel Lattice at the Centrosome , 1998, The Journal of cell biology.

[18]  Leland Hartwell,et al.  Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells , 1992, Cell.

[19]  S. Doxsey,et al.  Centrosome duplication continues in cycloheximide-treated Xenopus blastulae in the absence of a detectable cell cycle , 1990, The Journal of cell biology.

[20]  A. Merdes,et al.  Pathways of Spindle Pole Formation: Different Mechanisms; Conserved Components , 1997, The Journal of cell biology.

[21]  T. Hunter.  Oncoprotein Networks , 1997, Cell.

[22]  C. Rieder,et al.  Protein synthesis and the cell cycle: centrosome reproduction in sea urchin eggs is not under translational control , 1990, The Journal of cell biology.

[23]  D C Ward,et al.  Analysis of genes and chromosomes by nonisotopic in situ hybridization. , 1991, Genetic analysis, techniques and applications.

[24]  M. Kirschner,et al.  Mitosis in transition , 1994, Cell.

[25]  E. Salmon,et al.  Pathways of spindle assembly. , 1997, Current opinion in cell biology.

[26]  C. Rieder,et al.  The reproduction of centrosomes: nuclear versus cytoplasmic controls , 1986, The Journal of cell biology.

[27]  A. Murray,et al.  The spindle assembly checkpoint. , 1996, Current opinion in cell biology.

[28]  K W Kohn,et al.  Cell cycle control and cancer chemotherapy , 1994, Journal of cellular biochemistry.

[29]  D. Mazia.  The chromosome cycle and the centrosome cycle in the mitotic cycle. , 1987, International review of cytology.

[30]  D. Seckinger,et al.  DNA content in human cancer. Application in pathology and clinical medicine. , 1989, Archives of pathology & laboratory medicine.

[31]  R. Nicklas.  How Cells Get the Right Chromosomes , 1997, Science.

[32]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[33]  É. Mezey,et al.  Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[34]  J. Ross.  DNA Ploidy and Cell Cycle Analysis in Pathology , 1996 .

[35]  K. Shroyer,et al.  Time-related effects of enzymatic disaggregation on model human lung carcinomas. , 1995, Cytometry.

[36]  G. Woude,et al.  Abnormal Centrosome Amplification in the Absence of p53 , 1996, Science.